Bio-Techne Corporation
TECH
$48.21
$0.841.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 125.99% | 8.94% | 13.65% | -143.55% | -53.96% |
| Total Depreciation and Amortization | -12.34% | -8.77% | -13.49% | 8.92% | 0.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -5.58% | -- |
| Total Other Non-Cash Items | 351.19% | 75.30% | -33.48% | 293.27% | 4.99% |
| Change in Net Operating Assets | 67.00% | -84.81% | -340.06% | 310.73% | -1,038.32% |
| Cash from Operations | 110.75% | -2.29% | -56.82% | 30.07% | -49.23% |
| Capital Expenditure | 10.24% | 13.19% | 41.53% | 72.80% | 38.43% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 161.52% | -- | 110.80% | -49.43% | -- |
| Cash from Investing | 34.44% | -17.67% | 102.79% | 104.61% | 46.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -650.00% | -- | -142.11% | 28.57% | 86.21% |
| Issuance of Common Stock | 101.45% | -14.46% | -6.40% | -72.85% | -18.87% |
| Repurchase of Common Stock | 99.84% | 98.36% | -85.69% | -24,848.01% | -59,624.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.49% | 2.09% | 1.92% | 1.90% | -0.01% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 37.22% | 41.57% | -282.02% | -50.52% | -29.82% |
| Foreign Exchange rate Adjustments | -9.90% | 107.55% | -123.66% | 152.91% | 53.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 200.17% | 379.42% | -148.18% | 81.17% | -476.97% |